Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Borderline Personality Disorder01:25

Borderline Personality Disorder

Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Panic Disorder01:27

Panic Disorder

Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with the discrepancy between objective and subjective cognitive impairment in bipolar disorder.

Journal of affective disorders·2024
Same author

Alterations induced by titanium dioxide nanoparticles (nano-TiO<sub>2</sub>) in fertilization and embryonic and larval development of the tropical sea urchin Lytechinus variegatus.

Marine environmental research·2023
Same author

Corrigendum to "Resilience and mental health during the COVID-19 pandemic" [J. Affect. Disord. 2021 Mar 15;283:156-164].

Journal of affective disorders·2023
Same author

Corrigendum to "Effects of the COVID-19 pandemic and lockdown in Spain: Comparison between community controls and patients with a psychiatric disorder. Preliminary results from the BRIS-MHC STUDY" [J. Affect Disord. 2021 Feb 15; 281:13-23].

Journal of affective disorders·2023
Same author

Thresholds for severity, remission and recovery using the functioning assessment short test (FAST) in bipolar disorder.

Journal of affective disorders·2018
Same author

Development of VEGF-loaded PLGA matrices in association with mesenchymal stem cells for tissue engineering.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2017
Same journal

Silymarin Reverses Seizure-Precipitating Effects of Alcohol and Associated Psychiatric Comorbidities, and Neurotoxicity in Pentylenetetrazol Pre-Kindled Mice.

Neurotoxicity research·2026
Same journal

EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences.

Neurotoxicity research·2026
Same journal

In vivo Administration of Atorvastatin Does Not Impair Mitochondrial Function or Cellular Viability in the Prefrontal Cortex of Mice.

Neurotoxicity research·2026
Same journal

Prolonged In Vitro Exposure to Methylmalonic Acid Induces Inflammation, Glutamate Metabolism Disruption, and Alters Functional Gene Expression in C6 Astroglial Cells.

Neurotoxicity research·2026
Same journal

Carbamazepine-Induced Paroxysmal Dysarthria and Ataxia in an Elderly Patient: A Case Report and Clinical Considerations.

Neurotoxicity research·2026
Same journal

Impact of Chronic Mild Stress on Neurotrophic and Hypothalamic-Pituitary-Adrenal Factors in the Brain of Rats Submitted to Sepsis.

Neurotoxicity research·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Staging bipolar disorder.

Eduard Vieta1, M Reinares, A R Rosa

  • 1Bipolar Disorders Program, Institute of Neuroscience, Hospital Clínic Barcelona, University of Barcelona, IDIBAPS, CIBERSAM, Villarroel 170, 08036 Barcelona, Spain. evieta@clinic.ub.es

Neurotoxicity Research
|May 13, 2010
PubMed
Summary
This summary is machine-generated.

This study reviews evidence for a bipolar disorder staging model, suggesting earlier intervention improves treatment outcomes. Staging bipolar disorder aids in planning and prognosis, highlighting the need for early intervention.

Related Experiment Videos

Last Updated: Jun 13, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

  • Psychiatry
  • Neurology
  • Clinical Psychology

Background:

  • Bipolar disorder is a complex mental health condition with varying presentations.
  • Current treatment approaches often lack a framework for tracking illness progression.
  • Early intervention is crucial for managing chronic conditions effectively.

Purpose of the Study:

  • To analyze the evidence supporting a clinical staging model for bipolar disorder.
  • To explore the potential benefits of staging for treatment planning and prognosis.
  • To emphasize the importance of early intervention in bipolar disorder management.

Main Methods:

  • Extensive literature search of Medline and Pubmed databases.
  • Inclusion of articles using keywords such as 'staging', 'bipolar disorder', and 'early intervention'.
  • Detailed review and analysis of relevant published research.

Main Results:

  • Specific proposals for clinical staging in bipolar disorder have emerged recently.
  • A staging model suggests illness progression from prodromal to severe stages (Stage IV).
  • Staging involves longitudinal appraisal of clinical, functional, cognitive, and neurobiological factors.

Conclusions:

  • Staging models for bipolar disorder are based on improved treatment response with early intervention.
  • Earlier stages are associated with better prognosis and simpler treatment.
  • Clinical staging can significantly assist in bipolar disorder treatment planning and prognosis, underscoring the value of early intervention.